TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Clinical trial NCT07302776 · RECRUITING

Trial details

NCT number: NCT07302776
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

GVHD Hematopoietic Cell Transplantation (HCT)Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes Myelofibrosis (MF)Chronic Myeloid Leukemia (CML)Chronic Myelomonocytic Leukemia (CMML)

Start date: 2026-07-21
Primary completion: 2028-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.